Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025 ...

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Plus Therapeutics (PSTV – Research Report). The associated ...

G Shock ’s latest G-STEEL GBM-2100 is sharp, suave and icy. Here's our watch review of the exquisite timepiece.

Presented positive ReSPECT-GBM Phase 1/2 Trial update data at the 2024 Congress of Neurological Surgeons Annual Conference, ...

A new study identifies key genetic vulnerabilities in glioblastoma stem cells, revealing subtype-specific dependencies that ...

Dubai, United Arab Emirates: Gulf Business Machines (GBM), an end-to-end leading digital solutions provider and Splunk, a Cisco company and the cybersecurity and observability leader, today announced ...

Biomednewsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment With Berubicin Amid Strong Financial Position ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Inovio Pharmaceuticals ( INO -3.64%) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

GBM Resources, an ASX-listed mining company, has signed a farm-in agreement with Wise Walkers to earn up to a 70% joint venture interest in the Twin Hills Gold Project in Queensland. The deal is ...

Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients with leptomeningeal metastases (LM) Presented positive ReS ...